Transaction in Own Shares

Summary by AI BETAClose X

QinetiQ Group plc has purchased 580,845 ordinary shares for cancellation between June 8 and June 12, 2026, as part of its ongoing share buyback program. The weighted average purchase price per share was approximately 476 pence, with prices ranging from 467.20 pence to 487.20 pence. Following these transactions, the company's total number of ordinary shares in issue and total voting rights will be 518,691,209.

Disclaimer*

QinetiQ Group plc
16 June 2026
 

QinetiQ Group plc

Transaction in own shares

QinetiQ Group plc (the Company) announces that in the period 8 June 2026 to 12 June 2026 it purchased in aggregate 580,845 ordinary shares of 1 pence each (Shares) for cancellation through Deutsche Bank AG, London Branch (trading for these purposes as Deutsche Numis), in accordance with the authority granted by shareholders at the Annual General Meeting of the Company held on 17 July 2025, and pursuant to the latest tranche of its existing share buyback programme announced on 25 March 2026. Full details are set out below:

                                                                                                                     

Date

Venue

Weighted average price paid per share (GBp)

Aggregate number of shares purchased

Lowest price paid per share (GBp)

Highest price paid per share (GBp)

8 June 2026

London Stock Exchange

474.7423

80,000

467.40

477.80

Chi-X

(CXE)

474.9520

20,000

469.20

477.60

BATS

(BXE)

475.2639

23,845

470.20

477.80

9 June 2026

London Stock Exchange

476.9860

78,000

467.20

480.40

Chi-X

(CXE)

477.3026

20,000

473.60

480.60

BATS

(BXE)

477.1954

26,000

473.80

480.40

10 June 2026

London Stock Exchange

475.22

80,000

467.40

479.80

Chi-X

(CXE)

475.93

20,000

469.00

479.80

BATS

(BXE)

476.20

26,000

469.60

479.80

11 June 2026

London Stock Exchange

482.66

78,000

477.20

487.20

Chi-X

(CXE)

482.51

20,000

476.80

486.60

BATS

(BXE)

482.61

26,000

476.80

486.60

12 June 2026

London Stock Exchange

475.73

40,000

472.00

479.60

Chi-X

(CXE)

475.53

20,000

472.20

478.40

BATS

(BXE)

475.59

23,000

472.40

479.60

 

All shares purchased by the Company will be cancelled. 

Following settlement of the above transactions, the Company's total number of ordinary shares in issue, and its total voting rights, will be 518,691,209 ordinary shares. This figure may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest, or a change to their interest, in the Company under the Financial Conduct Authority's Disclosure and Transparency Rules. The Company does not hold any ordinary shares in treasury.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014, as amended, a full breakdown of the individual trades made by Deutsche Numis on behalf of the Company is available via the link below.

http://www.rns-pdf.londonstockexchange.com/rns/1846I_1-2026-6-12.pdf


This announcement will also be available on QinetiQ Group plc's website at: https://www.qinetiq.com/en/investors.

Enquiries to:

Andrew Carter, Group Director Investor Relations:

+44 (0) 7392 289116

Stephanie Mann, Group Head of Media Relations:

+44 (0) 7770 720268

James Field, Company Secretary:

+44 (0) 7841 662957

 

LEI: 213800S8OBDOZMCMUW34

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings